Publisert 28.07.2017

Research Council grant PES 2020

Regenics AS was today awarded a contribution from the Research Council from the PES2020 program for an above treshold rating of its SME Instruments 2 application of June 2017. 

 

The PES 2020 program is scheduled to stimulate excellence in Norways application for grants under the Horizon 2020 program. Regenics AS was in July 2017 awarded a "Seal of Excellence" for its  application under the SME Instruments 2 program entitled " Clinical Evaluation of first topical IL-1 beta inhibitor in mild to moderate psoriasis"

 This means scoring above treshold for "Impact" , Excellence" and "Quality and efficience of implementation"

 Read more about Regenics and the Horizon 2020 "Seal of Excellence" 

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.